Phone: +44 141 899 0081


Home / Category: Events

Adaptive Pathways, Biosimilars, Rare Diseases – ISPOR 19th Annual European Congress – 29 Oct-2 Nov 2016, Vienna, Austria

Adaptive Pathways and Patient AccessAn issue panel entitled Adaptive Pathways and Patient Access: Pushing Payer Boundaries or Facilitating New Payment Models? was held and moderated by Jacoline Bouvy, Scientific Adviser, National Institute for Health and Care Excellence (NICE), London, UK. Jacoline

Synergies between Regulatory and Health Technology Assessments – ISPOR 19th Annual European Congress – 29 Oct-2 Nov 2016, Vienna, Austria

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) opened last Monday its 19th Annual European Congress in Vienna, Austria with a plenary session entitled What Synergies Could Be Created Between Regulatory and Health Technology Assessments?The plenary discussion was moderated by

ESMO 2016 – Congress Highlights

Kinesys Oncology: ESMO Congress, Copenhagen, 7-11 October 2016 Update on Lung Cancers, plus selected highlights in other tumours  Lung Cancer: RCC, Prostate, SCLC, Gastro-Oesophageal Cancers: NSCLC AstraZeneca: Selumetinib misses primary endpoint. Durvalumab: 80%, 6-month survival in Phase I / II

Biosimilars Kinesys USA Nov 2015

Kinesys' CEO Gerry McGettigan will present on Regulatory & Commercial aspects of Biosimilars at the SMi Conference on 16 November 2015, Renaissance Woodbridge Hotel, Iselin, New Jersey. On 17 November, Gerry and Kinesys' Product Development Expert Graeme Deuchar will hold an interactive workshop